PanTheryx Welcomes Wild Medicine Practitioner Stuart Harris to Board of Directors


Dr Harris Joins PanTheryx Board of Directors to Help Advance Digestive and Immune Health Research and Consumer Awareness

PHÉNIX, September 28, 2021– (BUSINESS WIRE) – PanTheryx, an integrative digestive and immune health company, today announced the addition of N. Stuart Harris, MD to its board of directors. Dr Harris is head of the wild medicine division at Massachusetts General Hospital (MGH), which practices resource-limited medicine under austere conditions. As a member of the PanTheryx Board of Directors, Dr. Harris will work with the company’s management team and its scientific advisory board to advance research focused on probiotics and cow colostrum for digestive health and immune.

This press release features multimedia. View the full release here:

Dr Stuart Harris, chief of the division of wild medicine at Massachusetts General Hospital (MGH), joins the PanTherx board of directors. (Photo: Business Wire)

“We are delighted to welcome Dr. Harris to the PanTheryx Board of Directors as he brings a unique perspective to preventive health and wellness,” said David Abramson, Executive Chairman of the Board of PanTheryx. “Dr. Harris’ clinical and field research, along with his extensive experience working with diverse populations, will give PanTheryx new perspectives as we create high quality health and wellness products that target digestive health.” and immune.

Dr. Harris brings more than twenty years of experience in emergency medicine, clinical research and the interaction between the environment and human health. Dr Harris is a full-time attending physician in the Emergency Department at the MGH, Associate Professor of Emergency Medicine at Harvard Medical School, and Affiliate of the Arctic Initiative faculty at the Belfer Center, Harvard Kennedy School of Government .

Dr Harris graduated from Harvard Affiliated Emergency Medicine Residency in 2003. His research focuses on the study of the pathogenesis and treatment of disease at high altitudes and the relationship between climate change and human health. Its research teams are active on / in the Himalayas, Mount Kilimanjaro, the Andes, Alaska and far eastern Siberia and have been funded by the National Institutes of Health, the US DOD, the MGH and the HMS.

“As an expert in wild medicine and an emergency physician, I have experienced the power of good nutrition to keep all systems in the body at their optimum capacity by supporting the microbiome,” commented Dr. Stuart Harris. . “I am delighted to be a member of the PanTheryx Board of Directors to help impact clinical nutrition research and highlight how essential the digestive system is to health and wellness.”

To learn more about PanTheryx, please visit

About PanTheryx

PanTheryx â„¢ is a nutrition and biotechnology company engaged in the global commercialization of health and wellness solutions for the human and animal health markets. From cutting-edge research and supplying top-notch ingredients to marketing leading consumer brands, PanTheryx is committed to delivering revolutionary approaches for digestive, immune and microbiome health. As the world’s largest producer of colostrum, PanTheryx supplies its proprietary ingredients ColostrumOne â„¢ and La Belle® Colostrum to its partners serving the global human and animal health markets. In addition to the products it develops with its partners, PanTheryx’s consumer brand portfolio includes TruBiotics®, Goodgut®, Life’s First Naturals â„¢ and DiaResQ®. To learn more about PanTheryx, its consumer brands, and the ingredients in colostrum, please visit

See the source version on


Andrea Martin
Andrea D. Martin Consulting LLC for PanTheryx
Telephone: 443.927.6183
E: [email protected]


About Author

Comments are closed.